UCB Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$734.97 | $636.99 | 19.73% | 9 | $661.77B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$149.27 | $174.55 | 13.89% | 3 | $359.25B |
| MRK | Merck | Outperform |
2
|
$127.51 | $130.51 | 12.15% | 11 | $322.96B |
| ABBV | AbbVie | Outperform |
9
|
$163.79 | $178.42 | 12.95% | 11 | $289.23B |
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$572.38 | $591.94 | 8.32% | 1 | $218.49B |
| NOVN | Novartis | Hold |
10
|
CHF87.97 | CHF105.00 | 22.34% | 9 | CHF179.49B |
| AMGN | Amgen | Outperform |
4
|
$311.29 | $303.65 | 2.80% | 8 | $166.99B |
| SAN | Sanofi | Outperform |
16
|
91.30€ | 102.80€ | 19.39% | 9 | 114.00€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$43.99 | $58.15 | 22.76% | 10 | $89.17B |
| CSL | CSL | Outperform |
12
|
$275.80 | $205.51 | -26.34% | 5 | $133.28B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$64.78 | $87.82 | 23.49% | 14 | $80.78B |
| SHW | Sherwin Williams | Outperform |
15
|
$311.30 | $317.38 | 10.50% | 9 | $78.96B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 10.30% | 0 | ¥6.47T |
| LONN | Lonza Group | Buy |
16
|
CHF519.60 | CHF516.89 | 14.51% | 8 | CHF37.47B |
| PPG | PPG Industries | Outperform |
13
|
$132.92 | $159.04 | 17.36% | 1 | $31.28B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$13.98 | $11.59 | 14.45% | 9 | $15.83B |
| 4523 | Eisai | Outperform |
18
|
¥6.55k | ¥9.58k | 28.34% | 0 | ¥1.86T |
| INCY | Incyte | Outperform |
9
|
$53.76 | $77.05 | 46.02% | 8 | $11.89B |
| CRDA | Croda International Plc | Outperform |
18
|
£47.46 | £65.12 | 7.46% | 6 | £6.43B |
| APLS | Apellis Pharmaceuticals | Outperform |
6
|
$47.46 | $79.81 | 74.88% | 3 | $5.59B |
| WCH | Wacker Chemie | Outperform |
17
|
102.25€ | 145.36€ | 22.25% | 9 | 5.00€B |
| CLN | Clariant | Outperform |
18
|
CHF13.89 | CHF16.11 | 7.99% | 6 | CHF4.53B |
| XFOR | X4 Pharmaceuticals | Outperform |
4
|
$1.15 | $3.26 | 334.78% | 1 | $193.13M |
| OMER | Omeros | Hold |
11
|
$3.73 | $13.00 | -100.00% | 2 | $182.52M |
| DXB | Dimerix |
0
|
$0.36 | $0.00 | 61.11% | 0 | $159.38M | |
| BLRX | BioLineRx | - |
7
|
₪0.17 | ₪1.39 | -100.00% | 0 | ₪302.07M |
| IFRX | InflaRx N.V. | Outperform |
4
|
$1.38 | $9.44 | 401.45% | 2 | $79.49M |
| AKTX | Akari Therapeutics, Plc | - |
2
|
$1.36 | $80.00 | -100.00% | 0 | $9.39M |